1. Home
  2. DAKT vs STTK Comparison

DAKT vs STTK Comparison

Compare DAKT & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$17.98

Market Cap

963.2M

Sector

Industrials

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.50

Market Cap

792.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
STTK
Founded
1968
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
963.2M
792.9M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
DAKT
STTK
Price
$17.98
$6.50
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$10.00
AVG Volume (30 Days)
720.4K
817.3K
Earning Date
03-04-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
538.10
53.02
EPS
0.40
N/A
Revenue
$608,932,000.00
$1,000,000.00
Revenue This Year
$12.06
N/A
Revenue Next Year
$9.16
N/A
P/E Ratio
$44.15
N/A
Revenue Growth
6.89
N/A
52 Week Low
$17.09
$1.70
52 Week High
$28.27
$8.33

Technical Indicators

Market Signals
Indicator
DAKT
STTK
Relative Strength Index (RSI) 34.92 42.18
Support Level N/A $5.87
Resistance Level $20.80 $7.75
Average True Range (ATR) 0.76 0.30
MACD -0.10 -0.04
Stochastic Oscillator 12.17 32.33

Price Performance

Historical Comparison
DAKT
STTK

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: